Bharat Biotech and GSK Cut Malaria Vaccine Price to Save More Lives in Africa

Hyderabad-based Bharat Biotech and multinational pharmaceutical Corporation GlaxoSmithKline (GSK) have reached an agreement to make the world-first malaria vaccine, Mosquirix (RTS,S), affordable and more readily available to citizens of malar...

Apollo Launches CanWin to Unite and Empower Cancer Survivors

Apollo Cancer Centres (ACCs) announced the creation of "CanWin," a cancer support network that unites everyone in their cancer journey, as a major step towards commemorating National Cancer Survivors Month.

Illuccix Gains FDA Nod for Earlier Prostate Cancer Detection

According to Telix Pharmaceuticals Limited, a biopharmaceutical company based in Melbourne that specializes in the development and marketing of therapeutic and diagnostic radiopharmaceuticals as well as related medical technologies

Lupin Secures FDA Approval for Prucalopride Constipation Drug

Lupin Limited, a multinational pharmaceutical company based in Mumbai, informed that it has received final approval from the US FDA for its Abbreviated New Drug Application (ANDA) on Prucalopride Tablets 1 mg and 2 mg.

Dr Lal PathLabs Scales Genomics with Illumina's NovaSeq X

Dr Lal PathLabs has enhanced its genomic capabilities by acquiring Illumina's NovaSeq X Series to the dedicated genomics division Genevolve. This additional technology expands the lab's ability to provide rapid and reliable genomic information for...

Government Launches Rs 5000 Crore Scheme to Boost Pharma Innovation

The Department of Pharmaceuticals will be supporting the research and innovation in pharma and medical technology, as the department has released an online portal for a scheme of Rs.5,000 crore. India is one of the major pharmaceutical m...

India Rises in Global Pharma as 'China Plus 1' Takes Hold

India’s pharmaceutical sector is seeing early benefits, as global drugmakers begin to shift a portion of their outsourcing arrangements from China to Indian firms, following the China+1 strategy. Major Contract Research and Manufacturing...

Aurobindo's Dyrupeg Biosimilar Secures UK Regulator's Approval

CuraTeQ Biologics, a wholly owned step-down subsidiary of Aurobindo Pharma, has received marketing authorization for its biosimilar Dyrupeg from the UK Medicines and Healthcare products Regulatory Agency (MHRA). The approval is an important...

India's 1st Gender-Neutral HPV Shot Powers Serum's Cervavac Campaign

The Serum Institute of India (SII), the world's leading vaccine manufacturer by volume, launched Cervavac, India’s first indigenously manufactured gender-neutral quadrivalent HPV vaccine...

Biocon, NCSM Join Hands to Deliver Affordable Cancer Treatment

In a major milestone in equitable cancer treatment, Biocon Biologics partnered with the National Cancer Society of Malaysia (NCSM) to put into action a Patient Assistance Programme (PAP) in order to increase access to affordable, quality...

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.